SAB Biotherapeutics
SABS
SABS
34 hedge funds and large institutions have $25.4M invested in SAB Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
73% less capital invested
Capital invested by funds: $93.6M → $25.4M (-$68.1M)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.5M | |
| 2 | +$5.33M | |
| 3 | +$2.29M | |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$2M |
| 5 |
IFAM
Institutional & Family Asset Management
Fort Collins,
Colorado
|
+$571K |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$6.55M | |
| 3 | -$6.3M | |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$5.5M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$5.34M |